Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term eslicarbazepine acetate extension study in partial onset seizures
NCT00910247Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Aug 2009
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of eslicarbazepine acetate in epilepsy, sponsored by Sumitomo Pharma America. Started Aug 2009; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00910247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910247.